nodes	percent_of_prediction	percent_of_DWPC	metapath
Pramipexole—HTR2A—urine—urinary bladder cancer	0.00228	0.09	CbGeAlD
Pramipexole—SLC22A2—renal system—urinary bladder cancer	0.0016	0.0634	CbGeAlD
Pramipexole—DRD5—female reproductive system—urinary bladder cancer	0.0015	0.0593	CbGeAlD
Pramipexole—ADRA2C—prostate gland—urinary bladder cancer	0.0012	0.0476	CbGeAlD
Pramipexole—SLC22A1—renal system—urinary bladder cancer	0.00113	0.0448	CbGeAlD
Pramipexole—HTR2B—smooth muscle tissue—urinary bladder cancer	0.00108	0.0429	CbGeAlD
Pramipexole—ADRA2C—seminal vesicle—urinary bladder cancer	0.00102	0.0403	CbGeAlD
Pramipexole—ADRA2A—prostate gland—urinary bladder cancer	0.000961	0.038	CbGeAlD
Pramipexole—HTR1A—renal system—urinary bladder cancer	0.000935	0.037	CbGeAlD
Pramipexole—HTR1B—female reproductive system—urinary bladder cancer	0.000928	0.0367	CbGeAlD
Pramipexole—HTR1D—female reproductive system—urinary bladder cancer	0.000898	0.0355	CbGeAlD
Pramipexole—HTR2C—female reproductive system—urinary bladder cancer	0.000889	0.0352	CbGeAlD
Pramipexole—HTR2B—female reproductive system—urinary bladder cancer	0.000835	0.033	CbGeAlD
Pramipexole—ADRA2C—renal system—urinary bladder cancer	0.000821	0.0325	CbGeAlD
Pramipexole—SLC22A1—vagina—urinary bladder cancer	0.00082	0.0324	CbGeAlD
Pramipexole—ADRA2A—seminal vesicle—urinary bladder cancer	0.000813	0.0322	CbGeAlD
Pramipexole—ADRA2C—urethra—urinary bladder cancer	0.000807	0.0319	CbGeAlD
Pramipexole—HTR2B—vagina—urinary bladder cancer	0.000756	0.0299	CbGeAlD
Pramipexole—ADRA2A—urethra—urinary bladder cancer	0.000644	0.0255	CbGeAlD
Pramipexole—HTR2A—epithelium—urinary bladder cancer	0.000601	0.0238	CbGeAlD
Pramipexole—ADRA2C—vagina—urinary bladder cancer	0.000595	0.0235	CbGeAlD
Pramipexole—HTR2A—smooth muscle tissue—urinary bladder cancer	0.000579	0.0229	CbGeAlD
Pramipexole—HTR2A—renal system—urinary bladder cancer	0.000557	0.022	CbGeAlD
Pramipexole—ADRA2A—female reproductive system—urinary bladder cancer	0.000525	0.0208	CbGeAlD
Pramipexole—HTR2B—lymph node—urinary bladder cancer	0.000489	0.0193	CbGeAlD
Pramipexole—ADRA2A—vagina—urinary bladder cancer	0.000475	0.0188	CbGeAlD
Pramipexole—HTR2A—female reproductive system—urinary bladder cancer	0.000446	0.0176	CbGeAlD
Pramipexole—HTR2A—vagina—urinary bladder cancer	0.000403	0.016	CbGeAlD
Pramipexole—ADRA2C—lymph node—urinary bladder cancer	0.000385	0.0152	CbGeAlD
Pramipexole—ADRA2A—lymph node—urinary bladder cancer	0.000307	0.0121	CbGeAlD
Pramipexole—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.000297	0.000304	CcSEcCtD
Pramipexole—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000296	0.000304	CcSEcCtD
Pramipexole—Haematuria—Doxorubicin—urinary bladder cancer	0.000295	0.000303	CcSEcCtD
Pramipexole—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000295	0.000303	CcSEcCtD
Pramipexole—Urethral disorder—Epirubicin—urinary bladder cancer	0.000295	0.000302	CcSEcCtD
Pramipexole—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000293	0.000301	CcSEcCtD
Pramipexole—Epistaxis—Doxorubicin—urinary bladder cancer	0.000292	0.0003	CcSEcCtD
Pramipexole—Angiopathy—Methotrexate—urinary bladder cancer	0.000291	0.000299	CcSEcCtD
Pramipexole—Sinusitis—Doxorubicin—urinary bladder cancer	0.000291	0.000298	CcSEcCtD
Pramipexole—Immune system disorder—Methotrexate—urinary bladder cancer	0.00029	0.000298	CcSEcCtD
Pramipexole—Dizziness—Fluorouracil—urinary bladder cancer	0.00029	0.000298	CcSEcCtD
Pramipexole—Visual impairment—Epirubicin—urinary bladder cancer	0.00029	0.000297	CcSEcCtD
Pramipexole—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000289	0.000297	CcSEcCtD
Pramipexole—Chills—Methotrexate—urinary bladder cancer	0.000288	0.000296	CcSEcCtD
Pramipexole—Diarrhoea—Cisplatin—urinary bladder cancer	0.000284	0.000292	CcSEcCtD
Pramipexole—Alopecia—Methotrexate—urinary bladder cancer	0.000284	0.000291	CcSEcCtD
Pramipexole—Vomiting—Gemcitabine—urinary bladder cancer	0.000284	0.000291	CcSEcCtD
Pramipexole—Bradycardia—Doxorubicin—urinary bladder cancer	0.000283	0.00029	CcSEcCtD
Pramipexole—Mental disorder—Methotrexate—urinary bladder cancer	0.000281	0.000289	CcSEcCtD
Pramipexole—Rash—Gemcitabine—urinary bladder cancer	0.000281	0.000289	CcSEcCtD
Pramipexole—Dermatitis—Gemcitabine—urinary bladder cancer	0.000281	0.000288	CcSEcCtD
Pramipexole—Eye disorder—Epirubicin—urinary bladder cancer	0.000281	0.000288	CcSEcCtD
Pramipexole—Hypersensitivity—Etoposide—urinary bladder cancer	0.000281	0.000288	CcSEcCtD
Pramipexole—Tinnitus—Epirubicin—urinary bladder cancer	0.00028	0.000287	CcSEcCtD
Pramipexole—Erythema—Methotrexate—urinary bladder cancer	0.00028	0.000287	CcSEcCtD
Pramipexole—Malnutrition—Methotrexate—urinary bladder cancer	0.00028	0.000287	CcSEcCtD
Pramipexole—Headache—Gemcitabine—urinary bladder cancer	0.000279	0.000287	CcSEcCtD
Pramipexole—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000279	0.000286	CcSEcCtD
Pramipexole—Flushing—Epirubicin—urinary bladder cancer	0.000279	0.000286	CcSEcCtD
Pramipexole—Vomiting—Fluorouracil—urinary bladder cancer	0.000279	0.000286	CcSEcCtD
Pramipexole—Rhinitis—Doxorubicin—urinary bladder cancer	0.000279	0.000286	CcSEcCtD
Pramipexole—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000277	0.000284	CcSEcCtD
Pramipexole—Rash—Fluorouracil—urinary bladder cancer	0.000277	0.000284	CcSEcCtD
Pramipexole—Dermatitis—Fluorouracil—urinary bladder cancer	0.000276	0.000283	CcSEcCtD
Pramipexole—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000276	0.000283	CcSEcCtD
Pramipexole—Headache—Fluorouracil—urinary bladder cancer	0.000275	0.000282	CcSEcCtD
Pramipexole—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000275	0.000282	CcSEcCtD
Pramipexole—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000274	0.000281	CcSEcCtD
Pramipexole—Dysgeusia—Methotrexate—urinary bladder cancer	0.000274	0.000281	CcSEcCtD
Pramipexole—Asthenia—Etoposide—urinary bladder cancer	0.000273	0.00028	CcSEcCtD
Pramipexole—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000273	0.00028	CcSEcCtD
Pramipexole—Angiopathy—Epirubicin—urinary bladder cancer	0.000273	0.00028	CcSEcCtD
Pramipexole—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000273	0.00028	CcSEcCtD
Pramipexole—Immune system disorder—Epirubicin—urinary bladder cancer	0.000271	0.000278	CcSEcCtD
Pramipexole—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000271	0.000278	CcSEcCtD
Pramipexole—Back pain—Methotrexate—urinary bladder cancer	0.00027	0.000277	CcSEcCtD
Pramipexole—Chills—Epirubicin—urinary bladder cancer	0.00027	0.000277	CcSEcCtD
Pramipexole—Pruritus—Etoposide—urinary bladder cancer	0.000269	0.000276	CcSEcCtD
Pramipexole—Visual impairment—Doxorubicin—urinary bladder cancer	0.000268	0.000275	CcSEcCtD
Pramipexole—Alopecia—Epirubicin—urinary bladder cancer	0.000266	0.000272	CcSEcCtD
Pramipexole—Nausea—Gemcitabine—urinary bladder cancer	0.000265	0.000272	CcSEcCtD
Pramipexole—Vomiting—Cisplatin—urinary bladder cancer	0.000264	0.000271	CcSEcCtD
Pramipexole—Vision blurred—Methotrexate—urinary bladder cancer	0.000263	0.00027	CcSEcCtD
Pramipexole—Mental disorder—Epirubicin—urinary bladder cancer	0.000263	0.00027	CcSEcCtD
Pramipexole—Rash—Cisplatin—urinary bladder cancer	0.000262	0.000269	CcSEcCtD
Pramipexole—Dermatitis—Cisplatin—urinary bladder cancer	0.000262	0.000269	CcSEcCtD
Pramipexole—Erythema—Epirubicin—urinary bladder cancer	0.000262	0.000268	CcSEcCtD
Pramipexole—Malnutrition—Epirubicin—urinary bladder cancer	0.000262	0.000268	CcSEcCtD
Pramipexole—Diarrhoea—Etoposide—urinary bladder cancer	0.000261	0.000267	CcSEcCtD
Pramipexole—Nausea—Fluorouracil—urinary bladder cancer	0.00026	0.000267	CcSEcCtD
Pramipexole—Eye disorder—Doxorubicin—urinary bladder cancer	0.00026	0.000267	CcSEcCtD
Pramipexole—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000259	0.000266	CcSEcCtD
Pramipexole—Tinnitus—Doxorubicin—urinary bladder cancer	0.000259	0.000266	CcSEcCtD
Pramipexole—Anaemia—Methotrexate—urinary bladder cancer	0.000258	0.000265	CcSEcCtD
Pramipexole—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000258	0.000265	CcSEcCtD
Pramipexole—Flushing—Doxorubicin—urinary bladder cancer	0.000258	0.000265	CcSEcCtD
Pramipexole—Flatulence—Epirubicin—urinary bladder cancer	0.000258	0.000264	CcSEcCtD
Pramipexole—Tension—Epirubicin—urinary bladder cancer	0.000257	0.000263	CcSEcCtD
Pramipexole—Dysgeusia—Epirubicin—urinary bladder cancer	0.000256	0.000263	CcSEcCtD
Pramipexole—Nervousness—Epirubicin—urinary bladder cancer	0.000254	0.000261	CcSEcCtD
Pramipexole—Back pain—Epirubicin—urinary bladder cancer	0.000253	0.00026	CcSEcCtD
Pramipexole—Angiopathy—Doxorubicin—urinary bladder cancer	0.000252	0.000259	CcSEcCtD
Pramipexole—Malaise—Methotrexate—urinary bladder cancer	0.000252	0.000259	CcSEcCtD
Pramipexole—Dizziness—Etoposide—urinary bladder cancer	0.000252	0.000258	CcSEcCtD
Pramipexole—Muscle spasms—Epirubicin—urinary bladder cancer	0.000252	0.000258	CcSEcCtD
Pramipexole—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000251	0.000258	CcSEcCtD
Pramipexole—Vertigo—Methotrexate—urinary bladder cancer	0.000251	0.000258	CcSEcCtD
Pramipexole—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000251	0.000257	CcSEcCtD
Pramipexole—Leukopenia—Methotrexate—urinary bladder cancer	0.00025	0.000257	CcSEcCtD
Pramipexole—Chills—Doxorubicin—urinary bladder cancer	0.000249	0.000256	CcSEcCtD
Pramipexole—Nausea—Cisplatin—urinary bladder cancer	0.000247	0.000253	CcSEcCtD
Pramipexole—Vision blurred—Epirubicin—urinary bladder cancer	0.000247	0.000253	CcSEcCtD
Pramipexole—Alopecia—Doxorubicin—urinary bladder cancer	0.000246	0.000252	CcSEcCtD
Pramipexole—Cough—Methotrexate—urinary bladder cancer	0.000244	0.00025	CcSEcCtD
Pramipexole—Mental disorder—Doxorubicin—urinary bladder cancer	0.000244	0.00025	CcSEcCtD
Pramipexole—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000243	0.000249	CcSEcCtD
Pramipexole—Convulsion—Methotrexate—urinary bladder cancer	0.000242	0.000248	CcSEcCtD
Pramipexole—Vomiting—Etoposide—urinary bladder cancer	0.000242	0.000248	CcSEcCtD
Pramipexole—Malnutrition—Doxorubicin—urinary bladder cancer	0.000242	0.000248	CcSEcCtD
Pramipexole—Erythema—Doxorubicin—urinary bladder cancer	0.000242	0.000248	CcSEcCtD
Pramipexole—Anaemia—Epirubicin—urinary bladder cancer	0.000242	0.000248	CcSEcCtD
Pramipexole—Agitation—Epirubicin—urinary bladder cancer	0.00024	0.000247	CcSEcCtD
Pramipexole—Rash—Etoposide—urinary bladder cancer	0.00024	0.000246	CcSEcCtD
Pramipexole—Dermatitis—Etoposide—urinary bladder cancer	0.00024	0.000246	CcSEcCtD
Pramipexole—Headache—Etoposide—urinary bladder cancer	0.000239	0.000245	CcSEcCtD
Pramipexole—Flatulence—Doxorubicin—urinary bladder cancer	0.000239	0.000245	CcSEcCtD
Pramipexole—Chest pain—Methotrexate—urinary bladder cancer	0.000238	0.000244	CcSEcCtD
Pramipexole—Arthralgia—Methotrexate—urinary bladder cancer	0.000238	0.000244	CcSEcCtD
Pramipexole—Myalgia—Methotrexate—urinary bladder cancer	0.000238	0.000244	CcSEcCtD
Pramipexole—Tension—Doxorubicin—urinary bladder cancer	0.000238	0.000244	CcSEcCtD
Pramipexole—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000237	0.000243	CcSEcCtD
Pramipexole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000236	0.000242	CcSEcCtD
Pramipexole—Malaise—Epirubicin—urinary bladder cancer	0.000236	0.000242	CcSEcCtD
Pramipexole—Discomfort—Methotrexate—urinary bladder cancer	0.000235	0.000241	CcSEcCtD
Pramipexole—Nervousness—Doxorubicin—urinary bladder cancer	0.000235	0.000241	CcSEcCtD
Pramipexole—Vertigo—Epirubicin—urinary bladder cancer	0.000235	0.000241	CcSEcCtD
Pramipexole—Syncope—Epirubicin—urinary bladder cancer	0.000235	0.000241	CcSEcCtD
Pramipexole—Leukopenia—Epirubicin—urinary bladder cancer	0.000234	0.00024	CcSEcCtD
Pramipexole—Back pain—Doxorubicin—urinary bladder cancer	0.000234	0.00024	CcSEcCtD
Pramipexole—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000233	0.000239	CcSEcCtD
Pramipexole—Palpitations—Epirubicin—urinary bladder cancer	0.000231	0.000237	CcSEcCtD
Pramipexole—Confusional state—Methotrexate—urinary bladder cancer	0.00023	0.000236	CcSEcCtD
Pramipexole—Loss of consciousness—Epirubicin—urinary bladder cancer	0.00023	0.000236	CcSEcCtD
Pramipexole—Cough—Epirubicin—urinary bladder cancer	0.000228	0.000234	CcSEcCtD
Pramipexole—Vision blurred—Doxorubicin—urinary bladder cancer	0.000228	0.000234	CcSEcCtD
Pramipexole—Convulsion—Epirubicin—urinary bladder cancer	0.000227	0.000233	CcSEcCtD
Pramipexole—Infection—Methotrexate—urinary bladder cancer	0.000227	0.000233	CcSEcCtD
Pramipexole—Nausea—Etoposide—urinary bladder cancer	0.000226	0.000232	CcSEcCtD
Pramipexole—Hypertension—Epirubicin—urinary bladder cancer	0.000226	0.000232	CcSEcCtD
Pramipexole—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000225	0.00023	CcSEcCtD
Pramipexole—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000224	0.00023	CcSEcCtD
Pramipexole—Anaemia—Doxorubicin—urinary bladder cancer	0.000224	0.00023	CcSEcCtD
Pramipexole—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000223	0.000229	CcSEcCtD
Pramipexole—Chest pain—Epirubicin—urinary bladder cancer	0.000223	0.000228	CcSEcCtD
Pramipexole—Myalgia—Epirubicin—urinary bladder cancer	0.000223	0.000228	CcSEcCtD
Pramipexole—Arthralgia—Epirubicin—urinary bladder cancer	0.000223	0.000228	CcSEcCtD
Pramipexole—Agitation—Doxorubicin—urinary bladder cancer	0.000222	0.000228	CcSEcCtD
Pramipexole—Anxiety—Epirubicin—urinary bladder cancer	0.000222	0.000228	CcSEcCtD
Pramipexole—Skin disorder—Methotrexate—urinary bladder cancer	0.000222	0.000227	CcSEcCtD
Pramipexole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000221	0.000227	CcSEcCtD
Pramipexole—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000221	0.000226	CcSEcCtD
Pramipexole—Discomfort—Epirubicin—urinary bladder cancer	0.00022	0.000226	CcSEcCtD
Pramipexole—Malaise—Doxorubicin—urinary bladder cancer	0.000218	0.000224	CcSEcCtD
Pramipexole—Dry mouth—Epirubicin—urinary bladder cancer	0.000218	0.000223	CcSEcCtD
Pramipexole—Vertigo—Doxorubicin—urinary bladder cancer	0.000217	0.000223	CcSEcCtD
Pramipexole—Anorexia—Methotrexate—urinary bladder cancer	0.000217	0.000223	CcSEcCtD
Pramipexole—Syncope—Doxorubicin—urinary bladder cancer	0.000217	0.000223	CcSEcCtD
Pramipexole—Leukopenia—Doxorubicin—urinary bladder cancer	0.000217	0.000222	CcSEcCtD
Pramipexole—Confusional state—Epirubicin—urinary bladder cancer	0.000215	0.000221	CcSEcCtD
Pramipexole—Palpitations—Doxorubicin—urinary bladder cancer	0.000214	0.000219	CcSEcCtD
Pramipexole—Oedema—Epirubicin—urinary bladder cancer	0.000214	0.000219	CcSEcCtD
Pramipexole—Hypotension—Methotrexate—urinary bladder cancer	0.000213	0.000219	CcSEcCtD
Pramipexole—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000213	0.000218	CcSEcCtD
Pramipexole—Infection—Epirubicin—urinary bladder cancer	0.000212	0.000218	CcSEcCtD
Pramipexole—Cough—Doxorubicin—urinary bladder cancer	0.000211	0.000217	CcSEcCtD
Pramipexole—Shock—Epirubicin—urinary bladder cancer	0.00021	0.000215	CcSEcCtD
Pramipexole—Convulsion—Doxorubicin—urinary bladder cancer	0.00021	0.000215	CcSEcCtD
Pramipexole—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000209	0.000215	CcSEcCtD
Pramipexole—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000209	0.000214	CcSEcCtD
Pramipexole—Hypertension—Doxorubicin—urinary bladder cancer	0.000209	0.000214	CcSEcCtD
Pramipexole—Tachycardia—Epirubicin—urinary bladder cancer	0.000208	0.000214	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000208	0.000213	CcSEcCtD
Pramipexole—Skin disorder—Epirubicin—urinary bladder cancer	0.000207	0.000213	CcSEcCtD
Pramipexole—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000206	0.000212	CcSEcCtD
Pramipexole—Insomnia—Methotrexate—urinary bladder cancer	0.000206	0.000212	CcSEcCtD
Pramipexole—Myalgia—Doxorubicin—urinary bladder cancer	0.000206	0.000211	CcSEcCtD
Pramipexole—Chest pain—Doxorubicin—urinary bladder cancer	0.000206	0.000211	CcSEcCtD
Pramipexole—Arthralgia—Doxorubicin—urinary bladder cancer	0.000206	0.000211	CcSEcCtD
Pramipexole—Anxiety—Doxorubicin—urinary bladder cancer	0.000205	0.000211	CcSEcCtD
Pramipexole—Paraesthesia—Methotrexate—urinary bladder cancer	0.000205	0.00021	CcSEcCtD
Pramipexole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000205	0.00021	CcSEcCtD
Pramipexole—Discomfort—Doxorubicin—urinary bladder cancer	0.000204	0.000209	CcSEcCtD
Pramipexole—Anorexia—Epirubicin—urinary bladder cancer	0.000204	0.000209	CcSEcCtD
Pramipexole—Dyspnoea—Methotrexate—urinary bladder cancer	0.000203	0.000209	CcSEcCtD
Pramipexole—Somnolence—Methotrexate—urinary bladder cancer	0.000203	0.000208	CcSEcCtD
Pramipexole—Dry mouth—Doxorubicin—urinary bladder cancer	0.000202	0.000207	CcSEcCtD
Pramipexole—Dyspepsia—Methotrexate—urinary bladder cancer	0.000201	0.000206	CcSEcCtD
Pramipexole—Hypotension—Epirubicin—urinary bladder cancer	0.0002	0.000205	CcSEcCtD
Pramipexole—Confusional state—Doxorubicin—urinary bladder cancer	0.000199	0.000204	CcSEcCtD
Pramipexole—Decreased appetite—Methotrexate—urinary bladder cancer	0.000198	0.000203	CcSEcCtD
Pramipexole—Oedema—Doxorubicin—urinary bladder cancer	0.000198	0.000203	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000197	0.000202	CcSEcCtD
Pramipexole—Fatigue—Methotrexate—urinary bladder cancer	0.000197	0.000202	CcSEcCtD
Pramipexole—Infection—Doxorubicin—urinary bladder cancer	0.000196	0.000201	CcSEcCtD
Pramipexole—Pain—Methotrexate—urinary bladder cancer	0.000195	0.0002	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000195	0.0002	CcSEcCtD
Pramipexole—Shock—Doxorubicin—urinary bladder cancer	0.000194	0.000199	CcSEcCtD
Pramipexole—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000194	0.000199	CcSEcCtD
Pramipexole—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000193	0.000198	CcSEcCtD
Pramipexole—Insomnia—Epirubicin—urinary bladder cancer	0.000193	0.000198	CcSEcCtD
Pramipexole—Tachycardia—Doxorubicin—urinary bladder cancer	0.000193	0.000198	CcSEcCtD
Pramipexole—Skin disorder—Doxorubicin—urinary bladder cancer	0.000192	0.000197	CcSEcCtD
Pramipexole—Paraesthesia—Epirubicin—urinary bladder cancer	0.000192	0.000197	CcSEcCtD
Pramipexole—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000191	0.000196	CcSEcCtD
Pramipexole—Dyspnoea—Epirubicin—urinary bladder cancer	0.00019	0.000195	CcSEcCtD
Pramipexole—Somnolence—Epirubicin—urinary bladder cancer	0.00019	0.000195	CcSEcCtD
Pramipexole—Anorexia—Doxorubicin—urinary bladder cancer	0.000188	0.000193	CcSEcCtD
Pramipexole—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000188	0.000193	CcSEcCtD
Pramipexole—Dyspepsia—Epirubicin—urinary bladder cancer	0.000188	0.000193	CcSEcCtD
Pramipexole—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000187	0.000191	CcSEcCtD
Pramipexole—Decreased appetite—Epirubicin—urinary bladder cancer	0.000186	0.00019	CcSEcCtD
Pramipexole—Hypotension—Doxorubicin—urinary bladder cancer	0.000185	0.000189	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000184	0.000189	CcSEcCtD
Pramipexole—Fatigue—Epirubicin—urinary bladder cancer	0.000184	0.000189	CcSEcCtD
Pramipexole—Pain—Epirubicin—urinary bladder cancer	0.000183	0.000187	CcSEcCtD
Pramipexole—Constipation—Epirubicin—urinary bladder cancer	0.000183	0.000187	CcSEcCtD
Pramipexole—Urticaria—Methotrexate—urinary bladder cancer	0.000181	0.000186	CcSEcCtD
Pramipexole—Abdominal pain—Methotrexate—urinary bladder cancer	0.00018	0.000185	CcSEcCtD
Pramipexole—Body temperature increased—Methotrexate—urinary bladder cancer	0.00018	0.000185	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.00018	0.000185	CcSEcCtD
Pramipexole—Insomnia—Doxorubicin—urinary bladder cancer	0.000179	0.000183	CcSEcCtD
Pramipexole—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000177	0.000182	CcSEcCtD
Pramipexole—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000176	0.000181	CcSEcCtD
Pramipexole—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000176	0.000181	CcSEcCtD
Pramipexole—Somnolence—Doxorubicin—urinary bladder cancer	0.000176	0.00018	CcSEcCtD
Pramipexole—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000175	0.000179	CcSEcCtD
Pramipexole—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000174	0.000178	CcSEcCtD
Pramipexole—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000172	0.000176	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000171	0.000175	CcSEcCtD
Pramipexole—Fatigue—Doxorubicin—urinary bladder cancer	0.00017	0.000175	CcSEcCtD
Pramipexole—Urticaria—Epirubicin—urinary bladder cancer	0.00017	0.000174	CcSEcCtD
Pramipexole—Constipation—Doxorubicin—urinary bladder cancer	0.000169	0.000173	CcSEcCtD
Pramipexole—Pain—Doxorubicin—urinary bladder cancer	0.000169	0.000173	CcSEcCtD
Pramipexole—Abdominal pain—Epirubicin—urinary bladder cancer	0.000169	0.000173	CcSEcCtD
Pramipexole—Body temperature increased—Epirubicin—urinary bladder cancer	0.000169	0.000173	CcSEcCtD
Pramipexole—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000168	0.000172	CcSEcCtD
Pramipexole—Asthenia—Methotrexate—urinary bladder cancer	0.000164	0.000168	CcSEcCtD
Pramipexole—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000163	0.000167	CcSEcCtD
Pramipexole—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000162	0.000166	CcSEcCtD
Pramipexole—Pruritus—Methotrexate—urinary bladder cancer	0.000161	0.000166	CcSEcCtD
Pramipexole—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000157	0.000161	CcSEcCtD
Pramipexole—Urticaria—Doxorubicin—urinary bladder cancer	0.000157	0.000161	CcSEcCtD
Pramipexole—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000156	0.00016	CcSEcCtD
Pramipexole—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000156	0.00016	CcSEcCtD
Pramipexole—Diarrhoea—Methotrexate—urinary bladder cancer	0.000156	0.00016	CcSEcCtD
Pramipexole—Asthenia—Epirubicin—urinary bladder cancer	0.000153	0.000157	CcSEcCtD
Pramipexole—Pruritus—Epirubicin—urinary bladder cancer	0.000151	0.000155	CcSEcCtD
Pramipexole—Dizziness—Methotrexate—urinary bladder cancer	0.000151	0.000155	CcSEcCtD
Pramipexole—Diarrhoea—Epirubicin—urinary bladder cancer	0.000146	0.00015	CcSEcCtD
Pramipexole—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000146	0.000149	CcSEcCtD
Pramipexole—Vomiting—Methotrexate—urinary bladder cancer	0.000145	0.000149	CcSEcCtD
Pramipexole—Rash—Methotrexate—urinary bladder cancer	0.000144	0.000148	CcSEcCtD
Pramipexole—Dermatitis—Methotrexate—urinary bladder cancer	0.000144	0.000147	CcSEcCtD
Pramipexole—Headache—Methotrexate—urinary bladder cancer	0.000143	0.000147	CcSEcCtD
Pramipexole—Asthenia—Doxorubicin—urinary bladder cancer	0.000142	0.000145	CcSEcCtD
Pramipexole—Dizziness—Epirubicin—urinary bladder cancer	0.000141	0.000145	CcSEcCtD
Pramipexole—Pruritus—Doxorubicin—urinary bladder cancer	0.00014	0.000143	CcSEcCtD
Pramipexole—Vomiting—Epirubicin—urinary bladder cancer	0.000136	0.000139	CcSEcCtD
Pramipexole—Nausea—Methotrexate—urinary bladder cancer	0.000136	0.000139	CcSEcCtD
Pramipexole—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000135	0.000139	CcSEcCtD
Pramipexole—Rash—Epirubicin—urinary bladder cancer	0.000135	0.000138	CcSEcCtD
Pramipexole—Dermatitis—Epirubicin—urinary bladder cancer	0.000134	0.000138	CcSEcCtD
Pramipexole—Headache—Epirubicin—urinary bladder cancer	0.000134	0.000137	CcSEcCtD
Pramipexole—Dizziness—Doxorubicin—urinary bladder cancer	0.000131	0.000134	CcSEcCtD
Pramipexole—Nausea—Epirubicin—urinary bladder cancer	0.000127	0.00013	CcSEcCtD
Pramipexole—Vomiting—Doxorubicin—urinary bladder cancer	0.000126	0.000129	CcSEcCtD
Pramipexole—Rash—Doxorubicin—urinary bladder cancer	0.000125	0.000128	CcSEcCtD
Pramipexole—Dermatitis—Doxorubicin—urinary bladder cancer	0.000124	0.000128	CcSEcCtD
Pramipexole—Headache—Doxorubicin—urinary bladder cancer	0.000124	0.000127	CcSEcCtD
Pramipexole—Nausea—Doxorubicin—urinary bladder cancer	0.000117	0.00012	CcSEcCtD
